Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,350
Total Claims
$812K
Drug Cost
628
Beneficiaries
$1,293
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+53%
Opioid rate vs peers
4.0% vs 2.6% avg
+21%
Cost per patient vs peers
$1,293 vs $1,068 avg
+36%
Brand preference vs peers
12.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.0%
Opioid Rate
370
Opioid Claims
$8,162
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,136 claims · $638K
Generic: 8,144 claims · $170K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 83 | $82K |
| Apixaban | 65 | $58K |
| Rivaroxaban | 48 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $39K |
| Dulaglutide | 29 | $33K |
| Mirabegron | 57 | $32K |
| Semaglutide | 27 | $29K |
| Tirzepatide | 16 | $22K |
| Dapagliflozin Propanediol | 28 | $21K |
| Sitagliptin Phosphate | 20 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $14K |
| Budesonide/Formoterol Fumarate | 30 | $13K |
| Linagliptin | 15 | $12K |
| Linaclotide | 16 | $12K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About